TREM-1 isoforms in bacterial infections: to immune modulation and beyond

References

• Adly AA, Ismail EA, Andrawes NG, El-Saadany MA. 2014. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine. 65(2):184–191.
   PubMed Web of Science ®Google Scholar
• Ajmani S, Singh H, Chaturvedi S, Mishra R, Rai MK, Jain A, Misra DP, Agarwal V. 2019. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis. Clin Rheumatol. 38(4):997–1005.
   PubMed Web of Science ®Google Scholar
• Al-Asy HM, Gamal RM, Albaset AMA, Elsanosy MG, Mabrouk MM. 2017. New diagnostic biomarker in acute diarrhea due to bacterial infection in children. Int J Pediatr Adolescent Med. 4(2):75–80.
   Google Scholar
• Allcock RJ, Barrow AD, Forbes S, Beck S, Trowsdale J. 2003. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol. 33(2):567–577.
   PubMed Web of Science ®Google Scholar
• Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE. 2011. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds. Inflammation. 34(5):412–425.
   PubMed Web of Science ®Google Scholar
• Aoki N, Zganiacz A, Margetts P, Xing Z. 2004. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immun. 72(5):2477–2483.
   PubMed Web of Science ®Google Scholar
• Arts RJ, Joosten LA, van der Meer JW, Netea MG. 2013. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 93(2):209–215.
   PubMed Web of Science ®Google Scholar
• Barati M, Bashar FR, Shahrami R, Zadeh MHJ, Taher MT, Nojomi M. 2010. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care. 25(2):362.e361-366.
   Web of Science ®Google Scholar
• Baxt LA, Garza-Mayers AC, Goldberg MB. 2013. Bacterial subversion of host innate immune pathways. Science. 340(6133):697–701.
   PubMed Web of Science ®Google Scholar
• Begum NA, Ishii K, Kurita-Taniguchi M, Tanabe M, Kobayashi M, Moriwaki Y, Matsumoto M, Fukumori Y, Azuma I, Toyoshima K, et al. 2004. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages. Infect Immun. 72(2):937–948.
   PubMed Web of Science ®Google Scholar
• Belibasakis GN, Öztürk V, Emingil G, Bostanci N. 2014. Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in gingival crevicular fluid: association with clinical and microbiologic parameters. J Periodontol. 85(1):204–210.
   PubMed Web of Science ®Google Scholar
• Bellos I, Fitrou G, Daskalakis G, Thomakos N, Papantoniou N, Pergialiotis V. 2018. Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis. Inflamm Res. 67(7):571–578.
   PubMed Web of Science ®Google Scholar
• Ben Lagha A, Andrian E, Grenier D. 2019. Resveratrol attenuates the pathogenic and inflammatory properties of Porphyromonas gingivalis. Mol Oral Microbiol. 34(3):118–130.
   PubMed Web of Science ®Google Scholar
• Bisson C, Massin F, Lefevre PA, Thilly N, Miller N, Gibot S. 2012. Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM) -1 in severe periodontitis. J Clin Periodontol. 39(12):1141–1148.
   PubMed Web of Science ®Google Scholar
• Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL. 2003. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 170(7):3812–3818.
   PubMed Web of Science ®Google Scholar
• Bopp C, Hofer S, Bouchon A, Zimmermann JB, Martin E, Weigand MA. 2009. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol. 26(6):504–507.
   PubMed Web of Science ®Google Scholar
• Bosco MC, Raggi F, Varesio L. 2016. Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer. Curr Pharm Des. 22(41):6209–6233.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Belibasakis GN. 2012. Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 66(1):37–44.
   PubMedGoogle Scholar
• Bostanci N, Oztürk V, Emingil G, Belibasakis GN. 2013. Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis. J Dent Res. 92(2):161–165.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Thurnheer T, Belibasakis GN. 2011. Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis. Mol Immunol. 49(1-2):387–394.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. 2000. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 164(10):4991–4995.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, Colonna M. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410(6832):1103–1107.
   PubMed Web of Science ®Google Scholar
• Brenner T, Uhle F, Fleming T, Wieland M, Schmoch T, Schmitt F, Schmidt K, Zivkovic AR, Bruckner T, Weigand MA, et al. 2017. Soluble TREM-1 as a diagnostic and prognostic biomarker in patients with septic shock: an observational clinical study. Biomarkers. 22(1):63–69.
   PubMed Web of Science ®Google Scholar
• Brodsky IE, Medzhitov R. 2009. Targeting of immune signalling networks by bacterial pathogens. Nat Cell Biol. 11(5):521–526.
   PubMed Web of Science ®Google Scholar
• Carrasco K, Boufenzer A, Jolly L, Le Cordier H, Wang G, Heck AJ, Cerwenka A, Vinolo E, Nazabal A, Kriznik A, et al. 2019. TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cell Mol Immunol. 16(5):460–472.
   PubMed Web of Science ®Google Scholar
• Charles PE, Noel R, Massin F, Guy J, Bollaert PE, Quenot JP, Gibot S. 2016. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis. 16(1):559.
   PubMed Web of Science ®Google Scholar
• Chen HL, Hung CH, Tseng HI, Yang RC. 2008. Soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age. Japanese J Infect Dis. 61:31–35.
   PubMed Web of Science ®Google Scholar
• Chen LC, Laskin JD, Gordon MK, Laskin DL. 2008. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol. 84(2):145–155.
   PubMed Web of Science ®Google Scholar
• Cuvier V, Lorch U, Witte S, Olivier A, Gibot S, Delor I, Garaud J-J, Derive M, Salcedo-Magguilli M. 2018. A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition. Br J Clin Pharmacol. 84(10):2270–2279.
   PubMed Web of Science ®Google Scholar
• de Oliveira Matos A, Dos Santos Dantas PH, Figueira Marques Silva-Sales M, Sales-Campos H. 2020. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections. Crit Rev Microbiol. 46(3):237–252.
   PubMed Web of Science ®Google Scholar
• Denning N-L, Aziz M, Murao A, Gurien SD, Ochani M, Prince JM, Wang P. 2020. Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis. JCI Insight. 5(5):e134172.
   PubMed Web of Science ®Google Scholar
• Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max J-P, Ford J, Alauzet C, et al. 2012. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol. 188(11):5585–5592.
   PubMed Web of Science ®Google Scholar
• Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, Lozniewski A, Leroy P, Tran N, Gibot S, et al. 2013. Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock. 39(2):176–182.
   PubMed Web of Science ®Google Scholar
• Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T, Garrard CS, Schultz MJ. 2005. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med. 31(11):1495–1500.
   PubMed Web of Science ®Google Scholar
• Determann RM, Schultz MJ, Geerlings SE. 2007. Soluble triggering receptor expressed on myeloid cells-1 is not a sufficient biological marker for infection of the urinary tract. J Infect. 54(6):e249–e250.
   PubMedGoogle Scholar
• Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. 2006. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med. 32(8):1243–1247.
   PubMed Web of Science ®Google Scholar
• Dheda K, Lenders L, Srivastava S, Magombedze G, Wainwright H, Raj P, Bush SJ, Pollara G, Steyn R, Davids M, et al. 2019. Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing. Am J Respir Crit Care Med. 200(3):370–380.
   PubMed Web of Science ®Google Scholar
• Di Pillo E, Carrasco K, Brustolin B, Boufenzer A, Jolly L, Derive M, Lacolley P, Regnault V, Gibot S. 2020. Inhibition of triggering receptor expressed on myeloid cells-1 impairs thrombin generation. J Thromb Haemost. 18(2):454–462.
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Orfanos SE, Pelekanou A, Kotanidou A, Livaditi O, Augustatou C, Zervou M, Douka E, Theodorakopoulou M, Karagianni V, et al. 2009. Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes. Inflamm Res. 58(3):127–132.
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Pelekanou A, Mavrou I, Savva A, Tzanela M, Kotsaki A, Kardara M, Orfanos SE, Kotanidou A, Giamarellos-Bourboulis EJ, et al. 2012. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression. J Crit Care. 27(3):294–300.
   PubMed Web of Science ®Google Scholar
• Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL. 2008. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol. 180(5):3520–3534.
   PubMed Web of Science ®Google Scholar
• Dubar M, Carrasco K, Gibot S, Bisson C. 2018. Effects of Porphyromonas gingivalis LPS and LR12 peptide on TREM-1 expression by monocytes. J Clin Periodontol. 45(7):799–805.
   PubMed Web of Science ®Google Scholar
• El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. 2007. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 111(1):36–44.
   PubMed Web of Science ®Google Scholar
• El-Madbouly AA, El Sehemawy AA, Eldesoky NA, Abd Elgalil HM, Ahmed AM. 2019. Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis. IDR. 12:311–319.
   Google Scholar
• Feng JY, Su WJ, Pan SW, Yeh YC, Lin YY, Chen NJ. 2018. Role of TREM-1 in pulmonary tuberculosis patients- analysis of serum soluble TREM-1 levels. Sci Rep. 8(1):8223.
   PubMedGoogle Scholar
• Fortin CF, Lesur O, Fulop T. Jr. 2007. Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol. 19(1):41–50.
   PubMed Web of Science ®Google Scholar
• François B, Wittebole X, Ferrer R, Mira J-P, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, et al. 2020. Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial. Intensive Care Med. 46(7):1425–1437.
   PubMed Web of Science ®Google Scholar
• Fu L, Han L, Xie C, Li W, Lin L, Pan S, Zhou Y, Li Z, Jin M, Zhang A, et al. 2017. Identification of extracellular actin as a ligand for triggering receptor expressed on myeloid cells-1 signaling. Front Immunol. 8:917
   PubMed Web of Science ®Google Scholar
• Gattis JL, Washington AV, Chisholm MM, Quigley L, Szyk A, McVicar DW, Lubkowski J. 2006. The structure of the extracellular domain of triggering receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment. J Biol Chem. 281(19):13396–13403.
   PubMed Web of Science ®Google Scholar
• Gellatly SL, Hancock RE. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 67(3):159–173.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C. 2006. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis. Intensive Care Med. 32(2):237–243.
   PubMed Web of Science ®Google Scholar
• Gibot S, Buonsanti C, Massin F, Romano M, Kolopp-Sarda M-N, Benigni F, Faure GC, Béné M-C, Panina-Bordignon P, Passini N, et al. 2006. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun. 74(5):2823–2830.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Kolopp-Sarda M-N, Béné M-C, Faure G, Bollaert P-E, Levy B. 2005. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 33(4):792–796.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. 2004. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 350(5):451–458.
   PubMed Web of Science ®Google Scholar
• Gibot S, Jolly L, Lemarié J, Carrasco K, Derive M, Boufenzer A. 2019. Triggering receptor expressed on myeloid cells-1 inhibitor targeted to endothelium decreases cell activation. Front Immunol. 10:2314.
   PubMed Web of Science ®Google Scholar
• Gibot S, Kolopp-Sarda M-N, Béné M-C, Bollaert P-E, Lozniewski A, Mory F, Levy B, Faure GC. 2004. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 200(11):1419–1426.
   PubMed Web of Science ®Google Scholar
• Gibot S, Kolopp-Sarda M-N, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert P-E. 2004. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 141(1):9–15.
   PubMed Web of Science ®Google Scholar
• Gibot S, Le Renard P-E, Bollaert P-E, Kolopp-Sarda M-N, Béné M-C, Faure GC, Lévy B. 2005. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 31(4):594–597.
   PubMed Web of Science ®Google Scholar
• Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, Singer M, Bellingan G. 2007. TREM-1 promotes survival during septic shock in mice. Eur J Immunol. 37(2):456–466.
   PubMed Web of Science ®Google Scholar
• Gingras MC, Lapillonne H, Margolin JF. 2002. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 38(11):817–824.
   PubMed Web of Science ®Google Scholar
• Grover V, Pantelidis P, Soni N, Takata M, Shah PL, Wells AU, Henderson DC, Kelleher P, Singh S. 2014. A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study. PLoS One. 9(10):e109686.
   PubMed Web of Science ®Google Scholar
• Hommes TJ, Dessing MC, Veer C, Florquin S, Colonna M, de Vos AF, van der Poll T. 2015. Role of triggering receptor expressed on myeloid cells-1/3 in Klebsiella-derived pneumosepsis. Am J Respir Cell Mol Biol. 53(5):647–655.
   PubMed Web of Science ®Google Scholar
• Hommes TJ, Hoogendijk AJ, Dessing MC, Van't Veer C, Florquin S, Colonna M, de Vos AF, van der Poll T. 2014. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia. J Pathol. 233(4):357–367.
   PubMed Web of Science ®Google Scholar
• Horn J, Stelzner K, Rudel T, Fraunholz M. 2018. Inside job: Staphylococcus aureus host-pathogen interactions. Int J Med Microbiol. 308(6):607–624.
   PubMed Web of Science ®Google Scholar
• Horst SA, Linnér A, Beineke A, Lehne S, Höltje C, Hecht A, Norrby-Teglund A, Medina E, Goldmann O. 2013. Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes-induced sepsis. J Innate Immun. 5(6):581–590.
   PubMed Web of Science ®Google Scholar
• Hu LT, Du ZD, Zhao GQ, Qiu S, Jiang N, Lin J, Wang Q, Xu Q. 2015. TREM-1 expression in rat corneal epithelium with Aspergillus fumigatus infection. Int J Ophthalmol. 8:222–227.
   PubMed Web of Science ®Google Scholar
• Huang C-T, Lee L-N, Ho C-C, Shu C-C, Ruan S-Y, Tsai Y-J, Wang J-Y, Yu C-J. 2014. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Infect. 68(5):440–447.
   PubMed Web of Science ®Google Scholar
• Janeway CA, Jr., Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol. 20:197–216.
   PubMed Web of Science ®Google Scholar
• Jedynak M, Siemiątkowski A, Milewski R, Mroczko B, Szmitkowski M. 2019. Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock. AOMS. 15(3):713–721.
   Google Scholar
• Jeong SJ, Song YG, Kim CO, Kim HW, Ku NS, Han SH, Choi JY, Kim JM. 2012. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness. Shock. 37(6):574–578.
   PubMed Web of Science ®Google Scholar
• Jolly L, Carrasco K, Derive M, Lemarié J, Boufenzer A, Gibot S. 2018. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Cardiovasc Res. 114(6):907–918.
   PubMed Web of Science ®Google Scholar
• Jolly L, Lemarie J, Carrasco K, Popovic B, Derive M, Boufenzer A, Gibot S. 2017. Triggering Receptor Expressed on Myeloid cells-1: a new player in platelet aggregation. Thromb Haemost. 117(9):1772–1781.
   PubMed Web of Science ®Google Scholar
• Kelker MS, Foss TR, Peti W, Teyton L, Kelly JW, Wüthrich K, Wilson IA. 2004. Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. J Mol Biol. 342(4):1237–1248.
   PubMed Web of Science ®Google Scholar
• Kinane DF, Stathopoulou PG, Papapanou PN. 2017. Periodontal diseases. Nat Rev Dis Primers. 3:17038.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Keck K, Li X, Gilfillan S, Otero K, Baruah S, Meyerholz DK, Varga SM, Knudson CJ, Moninger TO, et al. 2013. Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest. 123(1):138–149.
   PubMed Web of Science ®Google Scholar
• Klotz SA, Ianas V, Elliott SP. 2011. Cat-scratch Disease. Am Fam Physician. 83(2):152–155.
   PubMed Web of Science ®Google Scholar
• Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T. 2004. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol. 173(12):7131–7134.
   PubMed Web of Science ®Google Scholar
• Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K. 2007. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 11(2):R38.
   PubMed Web of Science ®Google Scholar
• Koussoulas V, Giamarellos-Bourboulis EJ, Barbatzas C, Pimentel M. 2011. Serum sTREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease. Dig Dis Sci. 56(12):3590–3595.
   PubMed Web of Science ®Google Scholar
• Lagler H, Sharif O, Haslinger I, Matt U, Stich K, Furtner T, Doninger B, Schmid K, Gattringer R, de Vos AF, et al. 2009. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol. 183(3):2027–2036.
   PubMed Web of Science ®Google Scholar
• Lanks CW, Musani AI, Hsia DW. 2019. Community-acquired Pneumonia and Hospital-acquired Pneumonia. Med Clin North Am. 103(3):487–501.
   PubMed Web of Science ®Google Scholar
• Li B, Zhao Y, Liu C, Chen Z, Zhou D. 2014. Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol. 9(9):1071–1081.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang A, Chen B, Teng L, Wang Y, Chen H, Jin M. 2010. Response of swine spleen to Streptococcus suis infection revealed by transcription analysis. BMC Genomics. 11:556.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang H, Liu J, Chen B, Li G. 2014. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Mediat Inflamm. 2014:1–7.
   Web of Science ®Google Scholar
• Lin Y-T, Tseng K-Y, Yeh Y-C, Yang F-C, Fung C-P, Chen N-J. 2014. TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice. Infect Immun. 82(3):1335–1342.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang X, Zhang B, Mao WWei, Liu T, Sun M, Wu YHui. 2018. TREM1: A positive regulator for inflammatory response via NF-κB pathway in A549 cells infected with Mycoplasma pneumoniae. Biomed Pharmacother. 107:1466–1472.
   PubMed Web of Science ®Google Scholar
• Liu X, Shin S. 2019. Viewing Legionella pneumophila Pathogenesis through an Immunological Lens. J Mol Biol. 431(21):4321–4344.
   PubMed Web of Science ®Google Scholar
• Luo L, Zhou Q, Chen X-j, Qin S-m, Ma W-l, Shi H-z. 2010. Effects of the TREM-1 pathway modulation during empyema in rats. Chin Med J (Engl). 123(12):1561–1565.
   PubMed Web of Science ®Google Scholar
• Mahla RS, Reddy MC, Prasad DVR, Kumar H. 2013. Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology. Front Immunol. 4:248–248.
   PubMed Web of Science ®Google Scholar
• Marioli A, Koupetori M, Raftogiannis M, Patrani M, Antonakos N, Pavlaki M, Adamis G, Dougekou G, Damoraki G, Tsangaris I, et al. 2014. Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis. BMC Immunol. 15:585.
   PubMedGoogle Scholar
• Molad Y, Pokroy-Shapira E, Kaptzan T, Monselise A, Shalita-Chesner M, Monselise Y. 2013. Serum soluble triggering receptor on myeloid cells-1 (sTREM-1) is elevated in systemic lupus erythematosus but does not distinguish between lupus alone and concurrent infection. Inflammation. 36(6):1519–1524.
   PubMed Web of Science ®Google Scholar
• Morici L, Torres AG, Titball RW. 2019. Novel multi-component vaccine approaches for Burkholderia pseudomallei. Clin Exp Immunol. 196(2):178–188.
   PubMed Web of Science ®Google Scholar
• Natale G, Biagioni F, Busceti CL, Gambardella S, Limanaqi F, Fornai F. 2019. TREM receptors connecting bowel inflammation to neurodegenerative disorders. Cells. 8(10):1124.
   Web of Science ®Google Scholar
• Nedeva C, Menassa J, Puthalakath H. 2019. Sepsis: inflammation is a necessary evil. Front Cell Dev Biol. 7:108.
   PubMed Web of Science ®Google Scholar
• Netea MG, Azam T, Ferwerda G, Girardin SE, Kim S-H, Dinarello CA. 2006. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol. 80(6):1454–1461.
   PubMed Web of Science ®Google Scholar
• Oku R, Oda S, Nakada T-a, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Ito M, Iseki T, et al. 2013. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine. 61(1):112–117.
   PubMed Web of Science ®Google Scholar
• Phua J, Koay ESC, Zhang D, Tai LK, Boo XL, Lim KC, Lim TK. 2006. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J. 28(4):695–702.
   PubMed Web of Science ®Google Scholar
• Piroozmand A, Soltani B, Razavizadeh M, Matini AH, Moosavi GA, Salehi M, Soltani S. 2017. Comparison of gastric juice soluble triggering receptor expressed on myeloid cells and C-reactive protein for detection of Helicobacter pylori infection. Electron Phys. 9(12):6111–6119.
   Google Scholar
• Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Gonzalez A, Martinez-Iribarren A, Esquerda A. 2009. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 34(6):1383–1389.
   PubMed Web of Science ®Google Scholar
• Porfyridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris SA, Giamarellou H, Giamarellos-Bourboulis EJ. 2010. Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study. BMC Infect Dis. 10(1):286.
   PubMedGoogle Scholar
• Prufer S, et al. 2014. Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells. J Innate Immun. 6:339–352.
   PubMed Web of Science ®Google Scholar
• Radaev S, Kattah M, Rostro B, Colonna M, Sun PD. 2003. Crystal structure of the human myeloid cell activating receptor TREM-1. Structure. 11(12):1527–1535.
   PubMed Web of Science ®Google Scholar
• Radsak MP, Salih HR, Rammensee HG, Schild H. 2004. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 172(8):4956–4963.
   PubMed Web of Science ®Google Scholar
• Räisänen IT, Heikkinen AM, Pakbaznejad Esmaeili E, Tervahartiala T, Pajukanta R, Silbereisen A, Bostanci N, Sorsa T. 2020. A point-of-care test of active matrix metalloproteinase-8 predicts triggering receptor expressed on myeloid cells-1 (TREM-1) levels in saliva. J Periodontol. 91(1):102–109.
   PubMed Web of Science ®Google Scholar
• Ravetti CG, Moura AD, Vieira ÉL, Pedroso ÊR, Teixeira AL. 2015. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. J Crit Care. 30(2):440.e7–440.e13.
   Web of Science ®Google Scholar
• Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, Dantzler JL, Grell SN, Kastrup J, Wang C, et al. 2015. Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. J Immunol. 194(4):1417–1421.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordignon P, Fabbri LM, et al. 2004. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J. 24(2):247–250.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez FA, Huebinger RM, Burris A, Liu MM, Minei JP, Hunt JL, Arnaldo BD, Barber RC. 2013. A TREM-1 polymorphism A/T within the Exon 2 is associated with pneumonia in burn-injured patients. ISRN Inflamm. 2013:431739.
   PubMedGoogle Scholar
• Rivera-Chavez FA, Minei JP. 2009. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect. 10(5):435–439.
   PubMed Web of Science ®Google Scholar
• Rolli J, Loukili N, Levrand S, Rosenblatt-Velin N, Rignault-Clerc S, Waeber B, Feihl F, Pacher P, Liaudet L. 2010. Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice. Crit Care. 14(4):R160.
   PubMed Web of Science ®Google Scholar
• Routsi C, Giamarellos-Bourboulis EJ, Antonopoulou A, Kollias S, Siasiakou S, Koronaios A, Zakynthinos S, Armaganidis A, Giamarellou H, Roussos C, et al. 2005. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock? Clin Exp Immunol. 142(1):62–67.
   PubMed Web of Science ®Google Scholar
• Ruiz-González A, Esquerda A, Falguera M, Abdulghani N, Cabezas P, Bielsa S, Porcel JM. 2011. Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in community-acquired pneumonia. Respirology (Carlton, Vic.). 16(2):321–325.
   PubMed Web of Science ®Google Scholar
• Saldir M, Tunc T, Cekmez F, Cetinkaya M, Kalayci T, Fidanci K, Babacan O, Erdem G, Kocak N, Sari E, et al. 2015. Endocan and soluble triggering receptor expressed on myeloid cells-1 as novel markers for neonatal sepsis. Pediatr Neonatol. 56(6):415–421.
   PubMed Web of Science ®Google Scholar
• Sarafidis K, Soubasi-Griva V, Piretzi K, Thomaidou A, Agakidou E, Taparkou A, Diamanti E, Drossou-Agakidou V. 2010. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates. Intensive Care Med. 36(5):864–868.
   PubMed Web of Science ®Google Scholar
• Schenk M, Bouchon A, Seibold F, Mueller C. 2007. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest. 117(10):3097–3106.
   PubMed Web of Science ®Google Scholar
• Schmausser B, Endrich S, Beier D, Moran AP, Burek CJ, Rosenwald A, Rieckmann P, Müller-Hermelink H-K, Eck M. 2008. Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: implication for a role of TREM-1 in Helicobacter pylori infection. Clin Exp Immunol. 152(1):88–94.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang Y, Wang H, Zeng S. 2017. Effect of triggering receptor expressed on myeloid cells 1 (TREM-1) blockade in rats with cecal ligation and puncture (CLP)-induced sepsis. Med Sci Monit. 23:5049–5055.
   PubMed Web of Science ®Google Scholar
• Sigalov AB. 2014. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock. Int Immunopharmacol. 21(1):208–219.
   PubMed Web of Science ®Google Scholar
• Sigalov AB. 2020. SCHOOL of nature: ligand-independent immunomodulatory peptides. Drug Discov Today. 25(8):1298–1306.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Stein M, Schachter-Davidov A, Babai I, Tasher D, Somekh E. 2015. The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates. Clin Pediatr (Phila). 54(5):439–444.
   PubMed Web of Science ®Google Scholar
• Su L, Feng L, Song Q, Kang H, Zhang X, Liang Z, Jia Y, Feng D, Liu C, Xie L, et al. 2013. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediat Inflamm. 2013:1–9.
   Web of Science ®Google Scholar
• Su L, Han B, Liu C, Liang L, Jiang Z, Deng J, Yan P, Jia Y, Feng D, Xie L, et al. 2012. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis. 12(1):157.
   PubMedGoogle Scholar
• Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. 2017. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 177:81–95.
   PubMed Web of Science ®Google Scholar
• Tao F, Peng L, Li J, Shao Y, Deng L, Yao H. 2013. Association of serum myeloid cells of soluble triggering receptor-1 level with myocardial dysfunction in patients with severe sepsis. Mediat Inflamm. 2013:819246.
   PubMed Web of Science ®Google Scholar
• Tejera A, Santolaria F, Diez M-L, Alemán-Valls M-R, González-Reimers E, Martínez-Riera A, Milena-Abril A. 2007. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine. 38(3):117–123.
   PubMed Web of Science ®Google Scholar
• Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A. 2007. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J Immunol. 178(4):1991–1999.
   PubMed Web of Science ®Google Scholar
• Tintinger GR, van der Merwe JJ, Fickl H, Rheeder P, Feldman C, Anderson R. 2012. Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study. Eur J Clin Microbiol Infect Dis. 31(1):73–76.
   PubMed Web of Science ®Google Scholar
• Tong J, Liu ZC, Wang DX. 2011. Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis. Immunol Lett. 138(2):137–143.
   PubMed Web of Science ®Google Scholar
• van Bremen T, Drömann D, Luitjens K, Dodt C, Dalhoff K, Goldmann T, Schaaf B. 2013. Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis. Diagn Pathol. 8(1):24.
   PubMedGoogle Scholar
• Varanat M, Haase EM, Kay JG, Scannapieco FA. 2017. Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria. Mol Oral Microbiol. 32(4):275–287.
   PubMed Web of Science ®Google Scholar
• Wang B, Yao M, Lv L, Ling Z, Li L. 2017. The human microbiota in health and disease. Engineering. 3(1):71–82. doi:.
   Web of Science ®Google Scholar
• Wang F, Liu S, Wu S, Zhu Q, Ou G, Liu C, Wang Y, Liao Y, Sun Z. 2012. Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis. Cell Immunol. 272(2):251–258.
   PubMed Web of Science ®Google Scholar
• Wang HX, Chen B. 2011. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis. World J Emerg Med. 2(3):190–194.
   PubMedGoogle Scholar
• Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, De La Mota A, Schubert RL, Gomez-Rodriguez J, Cheng J, et al. 2009. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest. 119(6):1489–1501.
   PubMed Web of Science ®Google Scholar
• Weber B, Schuster S, Zysset D, Rihs S, Dickgreber N, Schürch C, Riether C, Siegrist M, Schneider C, Pawelski H, et al. 2014. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 10(1):e1003900.
   PubMed Web of Science ®Google Scholar
• Weehuizen TAF, Hommes TJ, Lankelma JM, de Jong HK, Roelofs JJTH, de Vos AF, Colonna M, van der Poll T, Wiersinga WJ. 2016. Triggering receptor expressed on myeloid cells (TREM)-2 impairs host defense in experimental melioidosis. PLoS Negl Trop Dis. 10(6):e0004747.
   PubMed Web of Science ®Google Scholar
• Weiss G, Lai C, Fife ME, Grabiec AM, Tildy B, Snelgrove RJ, Xin G, Lloyd CM, Hussell T. 2017. Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors. Mucosal Immunol. 10(4):1021–1030.
   PubMed Web of Science ®Google Scholar
• Willi M, Belibasakis GN, Bostanci N. 2014. Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases. Clin Exp Immunol. 178(1):190–200.
   PubMed Web of Science ®Google Scholar
• Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A. 2012. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res. 72(16):3977–3986.
   PubMed Web of Science ®Google Scholar
• Wu M, Peng A, Sun M, Deng Q, Hazlett LD, Yuan J, Liu X, Gao Q, Feng L, He J, et al. 2011. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Infect Immun. 79(7):2709–2716.
   PubMed Web of Science ®Google Scholar
• Wu Y, Fang Y-M, Ding L, Liu X, Francisco NM, Wen J, Liao C, Ma Z, Li Z, Li M, et al. 2018. Activation and regulation of blood Vδ2 T cells are amplified by TREM-1+ during active pulmonary tuberculosis. J Immunol. 200(5):1627–1638.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Calvacanti BM, Cruzat A, Qazi Y, Ishikawa S, Osuka A, Lederer J, Hamrah P. 2014. Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy. Invest Ophthalmol Vis Sci. 55(11):7457–7466.
   PubMed Web of Science ®Google Scholar
• Yang C, Chen B, Zhao J, Lin L, Han L, Pan S, Fu L, Jin M, Chen H, Zhang A, et al. 2015. TREM-1 signaling promotes host defense during the early stage of infection with highly pathogenic Streptococcus suis. Infect Immun. 83(8):3293–3301.
   PubMed Web of Science ®Google Scholar
• Yang C, Zhao J, Lin L, Pan S, Fu L, Han L, Jin M, Zhou R, Zhang A. 2015. Targeting TREM-1 signaling in the presence of antibiotics is effective against streptococcal toxic-shock-like syndrome (STSLS) caused by Streptococcus Suis. Front Cell Infect Microbiol. 5:79.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Syed MA, Panchal D, Joo M, Colonna M, Brantly M, Sadikot RT. 2014. Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival. J Biol Chem. 289(21):15118–15129.
   PubMed Web of Science ®Google Scholar
• Zhang J, She D, Feng D, Jia Y, Xie L. 2011. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect Dis. 11(1):53.
   PubMedGoogle Scholar
• Zhu J, Duan G, Wang H, Cao M, Liu Y. 2016. TREM-1 activation modulates dsRNA induced antiviral immunity with specific enhancement of MAPK signaling and the RLRs and TLRs on macrophages. Exp Cell Res. 345(1):70–81.
   PubMed Web of Science ®Google Scholar